Antineutrophil cytoplasm antibodies and vasculitis

Archives of Disease in Childhood

Volumn 77, Issue 3, 1997, Pages 261-264

  Nash, M C ^a   Dillon, M J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; LABORATORY DIAGNOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULITIS;

EID: 0030815574     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.77.3.261     Document Type: Review

References (46)

1. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? BMJ 1982;285:606.
3. Hall JB, Wadham BM, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N Z J Med 1984; 14:277-8.
4. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-9.
5. Walters MD, Savage CO, Dillon MJ, Lockwood CM, Barratt TM. Antineutrophil cytoplasm antibody in crescentic glomerulonephritis. Arch Dis Child 1988;63:814-17.
6. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
7. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl 1989;6:12-13.
8. Goldschmeding R, van der School CE, ten Bokkel Huinink D, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989;84:1577-87.
9. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
10. Stroncek DF, Egging MS, Eiber GA, Clay ME. Neutrophil alloantibodies react with cytoplasmic antigens: a possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens. Am J Kidney Dis 1993;21:368-73.
11. Savage CO, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987;i:1389-93.
12. Hagen EC. Standardisation of ANCA assays using purified proteinase-3 (PR3) and myeloperoxidase (MPO) [abst]. Clin Exp Immunol 1995;101:41.
13. Yang YH, Hutchinson P, Littlejohn GO, Boyce N. Flow cytometric detection of anti-neutrophil cytoplasmic autoantibodies. J Immunol Methods 1994;172:77-84.
14. Hagen EC, Ballieux BE, van Es LA, Daha MR, van der Woude FJ. Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 1993;81: 1996-2002.
15. Vaiopoulos G, Hatzinikolaou P, Tsiroyanni A, et al. Anti-neutrophil cytoplasmic antibodies in Adamantiadis-Behçet's disease. Br J Rheumatol 1994;33:406-7.
16. Rozenbaum M, Rosner I, Naschitz Y, Golan TD. Absence of antineutrophil cytoplasmic autoantibodies in Familial Mediterranean Fever. J Rheumatol 1995;22:376-7.
17. Davenport A, Lock RJ, Wallington TB, Feest TG. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay. Q J Med 1994;87:291-9.
18. Cohen Tervaert JW, Huitema MG, Hene RJ, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11.
19. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993;36:365-71.
20. Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum 1995;38:633-7.
21. Coremans IE, Hagen EC, Daha MR, et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466-75.
22. Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992;33:668-74.
23. Mulder AH, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CG. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993;17:411-7.
24. Helsloot J, Virgo S, McGuigan L, Sturgess A. Antineutrophil cytoplasmic antibodies in inflammatory arthritis: potential for misdiagnosis? Br J Rheumatol 1995;34:820-4.
25. Nassberger L, Ljungh A. β-Glucuronidase antibodies in ulcerative colitis. Lancet 1992;340:734-5.
26. O'Donoghue DJ, Nusbaum P, Noel L, Halbwachs-Mecarelli L, Lesavre P. Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura. Nephrol DialTransplant 1992; 7:534-8.
27. Sinico RA, Tadros M, Radice A, et al. Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy. Clin Immunol Immunopathol 1994;73:19-26.
28. Efthimiou J, Spickett G, Lane D, Thompson A. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet 1991;337:1037-8.
29. Weidemann S, Andrassy K, Ritz E. ANCA in haemodialysis patients. Nephrol DialTransplant 1993;8:839-45.
30. Wong S, Shah V, Dillon MJ. The spectrum of antineutrophil cytoplasmic antibodies (ANCA) in childhood systemic vasculitis [abst]. Clin Exp Immunol 1993;93:30.
31. Ellis EN, Wood EG, Berry P. Spectrum of disease associated with anti-neutrophil cytoplasmic autoantibodies in pediatric patients. J Pediatr 1995;126:40-3.
32. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 1994;124:986-8.
33. Winter HS, Landers CJ, Winkelstein A, Vidrich A, Targan SR. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr 1994;125:707-11.
34. Wong SN, Shah V, Dillon MJ. Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus. Eur J Pediatr 1995;154:43-5.
35. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 1992;42:951-6.
36. Savage CO, Tizard J, Jayne D, Lockwood CM, Dillon MJ. Antineutrophil cytoplasm antibodies in Kawasaki disease. Arch Dis Child 1989;64:360-3.
37. Guzman J, Fung M, Petty RE. Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease. J Pediatr 1994;124:917-20.
38. Nash MC, Shah V, Reader JA, Dillon MJ. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Br J Rheumatol 1995;34:882-7.
39. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994;95: 244-50.
40. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
41. Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-42.
42. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992;41:375-83.
43. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993;82: 1221-9.
44. Mayet WJ, Meyer zum Buschenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993;94: 440-6.
45. van de Wiel BA, Dolman KM, van der Meer Gerritsen CH, Hack CE, von dem Borne AE, Goldschmeding R. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin Exp Immunol 1992;90: 409-14.
46. Savige JA, Chang L, Cook L, Burdon J, Daskalakis M, Doery J. αa1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1995;100:194-7.